@article{Jolliffe_D-2022_98752,
title = {Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)},
author = {Jolliffe, D. and Holt, H. and Greenig, M. and Talaei, M. and Perdek, N. and Pfeffer, P. and Vivaldi, G. and Maltby, S. and Symons, J. and Barlow, N. and Normandale, A. and Garcha, R. and Richter, A. and Faustini, S. and Orton, C. and Ford, D. and Lyons, R. and Davies, G. and Kee, F. and Griffiths, C. and Norrie, J. and Sheikh, A. and Shaheen, S. and Relton, C. and Martineau, A.},
month = {sep},
year = {2022},
abstract = {OBJECTIVE: To determine the effect of population level implementation of a test-and-treat approach to correction of suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) &lt;75 nmol/L) on risk of all cause acute respiratory tract infection and covid 19.},
volume = {378},
issue = {8351},
journal = {The BMJ},
publisher = {BMJ Publishing Group},
url = {https://doi.org/10.1136/bmj-2022-071230},
}
